About: Mission

The founders of Correlogic Systems, Inc. envision a world where the ability to detect the relationship between a few seemingly inconsequential bits of data out of trillions may change the future of mankind.

Correlogic's mission is to advance the early identification of various cancers and other diseases, and to accelerate the new drug discovery process by applying its proprietary software to the development of proteomic and other biomarkers. We have created patented diagnostic software for use by both the scientific research and pharmaceutical research communities and the clinical diagnostic market. Through licensing, joint ventures and strategic alliances, we seek to work with manufacturers of protein separation and sequencing tools, diagnostic kit manufacturers, pharmaceutical companies, the academic research community and others to create turnkey diagnostic systems that will revolutionize the disease testing and screening market. Equally important, we also provide pattern discovery solutions to biotech and pharmaceutical companies for use in genomics, molecular biology, protein sequencing, and in new drug identification and toxicity evaluation.